Portfolio

The Accelerate Blue Fund works exclusively with companies spinning out from the University of Michigan. Since its inception in 2019, the AB Fund has invested in more than 40 startups. For more information on our portfolio companies, please see below, and make sure to check back as this page is continually updated to reflect AB Fund investments. 

AngioInsight provides a fully automated computer-based platform to medical practitioners to assist with coronary angiogram video interpretation.

Arcascope makes apps that utilize algorithms to track circadian rhythms and generate personalized recommendations.

Auricle, Inc. is a medical device company developing treatments for tinnitus, a chronic ringing in the ears that impacts up to 15% of people.

Accelerate Blue Foundry

Authentiq is developing embedded silicon fingerprinting for semiconductor authentication and trust.

BlueConduit is a water analytics company that has developed cutting-edge, predictive machine learning software to locate lead service lines, empowering local officials and their engineering partners with the information to efficiently remove those pipes.

BrightWater Tools develops building-scale wastewater nutrient recovery systems.

CubeWorksโ€™ CubiSensโ„ข Platform empowers ubiquitous wireless sensing, smart processing and energy harvesting โ€“ all in unprecedented, millimeter-scale form factors.

Decimal Code captures underbilled revenue for healthcare providers using automated CPT coding.

Accelerate Blue Foundry

Duvera Bio is redefining acne therapy with a next-generation retinoid that delivers unmatched efficacy without the harsh side effects.

Ecovia Renewables is creating high-performing water soluble and water swellable biopolymers for personal care, agricultural and industrial applications.

Accelerate Blue Foundry

Enexa Bio is developing precision immunology solutions for lupus and interferon-driven autoimmune diseases.

EnrollNow (formerly Ripple Sciences, Inc.) is providing technology to solve patient recruitment and retention challenges, the #1 reason cited when clinical trials fail.

Fifth Eye is developing an FDA cleared AI powered patient monitoring solution that identifies patient compensation and predicts hemodynamic instability.

Fourth State is creating a plasma reactor for PFAS removal.

Accelerate Blue Foundry

General Orbit is developing a hybrid AC/DC magnetometer with attitude determination and control system.

Genevi Technologies is developing a platform focused on the treatment of all forms of urinary incontinence starting with Urethral Health.

GripFusion is creating a grip sensing baseball to provide unparalleled insights into technique and injury prevention.

Heat2Power is creating highly efficient thermophotovoltaic panels that extract more electricity from high-temperature energy sources at scales ranging from kWs to MWs.

INHERET supports those affected by hereditary cancer, through easy-to-use tools that capture important family health history, assess risks and inform patients and families on the next best steps toward protecting their health.

Intero Biosystems is developing human stem cell-derived mini-organs to transform preclinical testing, accelerating the discovery of safer, more effective drugs before human clinical trials.

Lumetec provides software and data to detect environmental conditions on and around fiber optic cables.

M3D offers a variety of radiation gamma cameras for use in healthcare facilities by surgeons, physicians, physicists and environmental safety personnel.

Media Shield

Accelerate Blue Foundry

Media Shield is an AI-driven platform protecting enterprises from misinformation and digital fakes.

Accelerate Blue Foundry

Medication Data Science is creating real-time AI for medication verification to reduce prescription errors and improve pharmacy safety.

Medsyn

Medsyn is developing targeted protein degraders and molecular glues for oncology and immunologic disorders.

MemryX Inc. is a fabless semiconductor company that designs edge AI processing solutions powered by a proprietary compute-at-memory technology and data-flow architecture.

Mountain Pass offers a faculty position management software that brings proven workflow efficiency and accuracy to medical schools, universities and health systems.

Movellus Circuits is developing end to end Solutions for High Performance and Ultra Low Power SoCs (Systems on Chips)

Neurable is building full-stack neurotechnology tools that interpret human intent, measure emotion and provide telekinetic control of the digital world.

NewHaptics is a microfluidic technology company that specializes in full-page digital braille and tactile graphics displays.

NX Fuels is providing cost effective, sustainable solutions for production of green fuels (such as H2, CH4, etc.) from CO2 and water using only renewable solar energy.

NuLynx

NuLynx is developing first-in-field oncology therapeutics including orally bioavailable degraders and inhibitors targeting CDK12/13, PIKfyve, NSD2/1, and UBA1.

Ocutheia is creating a long-acting intravitreal therapeutic with broad efficacy for retinal neuroprotection and macular neovascularization.

ONL Therapeutics is developing innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

Pathways GI is maximizing Endoscopic Video Interpretation for Inflammatory Bowel Disease.

Poas Bioenergy is providing gasification technology that takes in the biomass and agricultural waste to produce high energy density syngas and biochar.

Saros Therapeutics is creating immunotherapies to improve and extend the lives of patients with cancer. A novel nanoparticle system safely targets and enhances pathways of innate immune activation.

SignetRisk Analytics is creating consistent cyber security compliance reports for cyber insurance applications.

Skeletalis has developed a sustainable approach to osteoporosis therapy by treating its root cause with a tissue and disease-specific platform. Their small-molecule delivery platform is uniquely capable of inhibiting bone resorption and decreasing fracture risk without inhibiting bone formation.

Sonovascular is developing a therapeutic ultrasound-based solution for vascular care (DVT).

SpellBreaker is developing deepfake detection using neurosymbolic AI.

Ulendo is a cloud-based 3D printing software that enables faster and more accurate printing leading to higher quality parts with less waste.

Volt Harbor is addressing the impending challenge of managing the rising number of used electric vehicle (EV) batteries and the increasing demand for Battery Energy Storage Systems (BESS). They repurpose used EV batteries to develop second-life BESS that is cheaper and more sustainable.

Zakuro is an energy storage company developing energy-dense solid-state batteries for Li-ion replacement.